BANB Bachem Holding AG

94.57USD79.70 CHF · SWX+0.44%Mkt Cap: 7.09B USDP/E: 40.25

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, …

Institutional holders10 on file

Key Statistics

Company
Market Cap7.09B USD
Enterprise Value7.28B USD
Revenue (TTM)840.76M USD
Gross Profit237.01M USD
Net Income (TTM)176.56M USD
Revenue/Share11.20 USD
Last Price94.57 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.7K
CountryCH
SectorHealthcare
IndustryBiotechnology
ISINCH1176493729
Valuation
P/E (Trailing)40.25
P/E (Forward)25.88
PEG0.61
EV/EBITDA29.16
EV/Revenue8.66
P/S8.43
P/B4.14
EPS (TTM)2.35 USD
EPS (Forward)3.65 USD
52W Range
57.5883% of range102.05
52W High102.05 USD
52W Low57.58 USD
Profitability
Gross Margin28.74%
Oper. Margin21.81%
EBITDA Margin29.70%
Profit Margin21.41%
ROE10.20%
ROA7.06%
ROIC—
ROCE9.82%
Growth
Revenue Growth4.30%
Earnings Growth0.00%
Cash Flow & Leverage
Operating CF322.26M USD
CapEx (TTM)390.87M USD
FCF Margin-29.24%
FCF Yield-3.47%
Net Debt185.74M USD
Net Debt/EBITDA0.74
Net Debt/FCF—
Balance Sheet
Debt/Equity14.41
Current Ratio1.60
Quick Ratio0.46
Book Value/Sh22.83 USD
Cash/Share0.82 USD
Dividends
Fwd Div Rate1.07 USD
Trail. Div Rate1.07 USD
Div. Yield1.13%
5Y Avg Yield1.02%
Payout Ratio45.45%
Ex-Div DateMay 4, 2026
Pay DateMay 7, 2025
Splits
Last Split5:1
Split DateMay 5, 2022
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.03 USD
Upside (mean)+5.8%
Target Range59.33 USD – 130.53 USD
59.33+5.8% to mean130.53
# Analysts10
Ownership
Shares Out.74.94M
Float31.25M
Insiders0.25%
Institutions82.70%
Technical
SMA 5096.07 (-1.6%)
SMA 20086.54 (+9.3%)
Beta0.76
S&P 52W Chg12.00%
Avg Vol (30d)83.06K
Avg Vol (10d)71.60K
Technical Indicators
RSI (14)46.4
MACD-0.6895
MACD Signal-0.3575
MACD Hist.-0.3320
BB Upper101.19 USD
BB Middle96.30 USD
BB Lower91.41 USD
BB Width10.15%
ATR (14)2.639 USD
Vol Ratio (20d)0.76x

About Bachem Holding (SWX: BANB)

›

Bachem Holding (SWX: BANB) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 2,725 employees.

The shares were at 79.70 CHF on 19 November 2026, up 56.3% over 52 weeks. Its 52-week range is 48.52 CHF to 86.00 CHF: the price is 7.3% below the high and 64.3% above the low.

At a market capitalisation of 5.97B CHF, it trades at 40.3 times trailing earnings and 25.9 times forward earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.5, a premium of 20% for BANB. It pays a dividend yielding 1.13% (it pays out 45% of its earnings), against a median of 0.94% among the dividend payers in that peer group.

Bachem Holding reports return on equity of 10.2%, an operating margin of 21.8% and revenue up 4.3% year over year.

Its debt exceeds its cash by 156.53M CHF, a debt-to-equity ratio of 14.41. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 10 analysts cover the stock, with an average rating of Buy; their mean price target of 84.30 CHF is 5.8% above the current price. The next earnings report is expected on 4 March 2027.